Skip to main content

Table 2 Summary of serum chemical data

From: Comparative effect of olmesartan and candesartan on lipid metabolism and renal function in patients with hypertension: a retrospective observational study

Laboratory test

Olmesartan (n = 168)

Candesartan (n = 266)

 

Mean

95% CI

p-value

Mean

95% CI

p-value

  

Lower

Upper

  

Lower

Upper

 

Lipid metabolism

       

   Triglyceride (mmol/L)

       

Baseline

1.87

1.68

2.06

 

1.69

1.48

1.91

 

Exposure

1.76

1.58

1.94

0.3912

1.81

1.65

1.97

0.3862

   LDL-cholesterol (mmol/L)

       

Baseline

3.01

2.88

3.14

 

3.14

3.05

3.24

 

Exposure

2.93

2.81

3.05

0.3609

3.09

2.99

3.19

0.4478

   Total cholesterol (mmol/L)

      

Baseline

5.25

5.10

5.40

 

5.34

5.21

5.46

 

Exposure

5.14

4.99

5.28

0.2871

5.31

5.19

5.43

0.7509

Kidney function

       

   Urea nitrogen (mmol/L)

      

Baseline

5.63

5.29

5.97

 

5.75

5.49

6.00

 

Exposure

5.92

5.50

6.34

0.2969

6.03

5.71

6.34

0.1743

   Creatinine (μmol/L)

       

Baseline

70.00

66.57

73.44

 

75.58

72.04

79.13

 

Exposure

72.31

68.66

75.95

0.3645

78.20

74.11

82.30

0.3416

   Potassium (mmol/L)

       

Baseline

4.40

4.34

4.47

 

4.32

4.27

4.36

 

Exposure

4.47

4.41

4.54

0.1161

4.36

4.31

4.41

0.2339

  1. p value: baseline vs exposure. CI denotes confidence interval. The mean values of all parameters showed no significant change between baseline and during the exposure period.